https://orcid.org/0000-0003-0191-1909
References
- Gestational Hypertension and Preeclampsia. ACOG Practice Bulletin No. 222. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2020;135:e237–e260.
- Bain ES, Middleton PF, Crowther CA. Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review. BMC Pregnancy Childbirth. 2013;13:195.
- Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002;359(9321):1877–1890.
- Duley L, Matar HE, Almerie MQ, et al. Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia. Cochrane Database Syst Rev. 2010;CD007388.
- Creasy RK, Resnik R, Iams JD. 2009. Creasy and Resnik's maternal–fetal medicine: principles and practice. 6th ed. Philadelphia (PA): Saunders/Elsevier.
- Abalos E, Cuesta C, Carroli G, et al. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014;121(Suppl. 1):14–24.
- Kashanian M, Koohpayehzadeh J, Sheikhansari N, et al. A comparison between the two methods of magnesium sulfate administration for duration of 12 versus 24 h after delivery in patients with severe preeclampsia. J Matern Fetal Neonatal Med. 2016;29(14):2282–2287.
- El-Khayat W, Atef A, Abdelatty S, et al. A novel protocol for postpartum magnesium sulphate in severe pre-eclampsia: a randomized controlled pilot trial. J Matern Fetal Neonat Med. 2016;29(1):154–158.
- Yifu P, Lei Y, Yujin G, et al. Shortened postpartum magnesium sulfate treatment vs traditional 24h for severe preeclampsia: a systematic review and meta-analysis of randomized trials. Hypertens Pregnancy. 2020;39(2):186–195.
- McLendon K, Goyal A, Bansal P, et al. Deep venous thrombosis risk factors; [updated 2020 Apr 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020.
- Nicolle LE. Catheter associated urinary tract infections. Antimicrob Resist Infect Control. 2014;3:23.
- Anjum S, Rajaram GP, Bano I. Short-course postpartum (6-h) magnesium sulfate therapy in severe preeclampsia. Arch Gynecol Obstet. 2016;293(5):983–986.
- Darngawn L, Jose R, Regi A, et al. A shortened postpartum magnesium sulfate prophylaxis regime in pre‐eclamptic women at low risk of eclampsia. Int J Gynecol Obstet. 2012;116(3):237–239.
- Ehrenberg HM, Mercer BM. Abbreviated postpartum magnesium sulfate therapy for women with mild preeclampsia: a randomized controlled trial. Obstet Gynecol. 2006;108(4):833–838.
- Fontenot MT, Lewis DF, Frederick JB, et al. A prospective randomized trial of magnesium sulfate in severe preeclampsia: use of diuresis as a clinical parameter to determine the duration of postpartum therapy. Am J Obstet Gynecol. 2005;192(6):1788–1793.
- Maia SB, Katz L, Neto CN, et al. Abbreviated (12-hour) versus traditional (24-hour) postpartum magnesium sulfate therapy in severe pre-eclampsia. Int J Gynaecol Obstet. 2014;126(3):260–264.
- Unwaha EA, Bello FA, Bello OO, et al. Intravenous magnesium sulfate in the management of severe pre-eclampsia: a randomized study of 12-hour versus 24-hour maintenance dose. Int J Gynaecol Obstet. 2020;149(1):37–42.
- Vigil-De Gracia P, Ramirez R, Duran Y, et al. Magnesium sulfate for 6 vs 24 hours post delivery in patients who received magnesium sulfate for less than 8 hours before birth: a randomized clinical trial. BMC Pregnancy Childbirth. 2017;17(1):241.